Recursion Pharmaceuticals
RXRX
#4090
Rank
HK$17.56 B
Marketcap
HK$45.18
Share price
-3.89%
Change (1 day)
-15.48%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$1.57 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are HK$1.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$1.48 B-11.74%
2022-12-31HK$1.68 B220.32%
2021-12-31HK$0.52 B-86.57%
2020-12-31HK$3.91 B122.66%
2019-12-31HK$1.75 B